Development and Characterization of Lansoprazole Nanosponges for Enhanced Solubility and Controlled Drug Release-Reference-Cited by-同舟云学术

Development and Characterization of Lansoprazole Nanosponges for Enhanced Solubility and Controlled Drug Release

Published:2024-08-27 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

PATEL ADIL¹,PATEL RICHA¹

Affiliation:

1. Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology (CHARUSAT), CHARUSAT Campus

Abstract

This study presents the preparation and characterization of Lansoprazole nanosponges using soluble chitosan, polyvinyl alcohol (PVA), and Pluronic F68 via the emulsion solvent diffusion method. The nanosponges were formulated to enhance the drug's solubility and controlled release profile. Differential Scanning Calorimetry (DSC) confirmed the transition of Lansoprazole to an amorphous state, indicating uniform distribution within the nanosponge matrix. Scanning Electron Microscopy (SEM) revealed spherical, porous nanosponges. Dynamic Light Scattering (DLS) analysis showed an average particle size of 332.4 nm with a moderate polydispersity index (PDI) of 0.52, while zeta potential measurements indicated moderate stability with a value of -15.3 mV. Fourier-transform infrared (FTIR) spectroscopy confirmed the entrapment of Lansoprazole without significant interactions with the polymers. The in vitro drug release study demonstrated a controlled and sustained release profile, achieving nearly complete drug release over 11 hours. These findings suggest that the prepared Lansoprazole nanosponges possess the desired characteristics for potential therapeutic applications, offering improved solubility, stability, and a controlled release mechanism.

Publisher

Springer Science and Business Media LLC

Reference14 articles.

1. 1. Khafagy ES, Abu Lila AS, Sallam NM, Sanad RA, Ahmed MM, Ghorab MM, Alotaibi HF, Alalaiwe A, Aldawsari MF, Alshahrani SM, Alshetaili A. Preparation and Characterization of a Novel Mucoadhesive Carvedilol Nanosponge: A Promising Platform for Buccal Anti-Hypertensive Delivery. Gels. 2022 Apr 11;8(4):235.

2. 2. Bhowmik H, Venkatesh DN, Kuila A, Kumar KH. Nanosponges: A review. International journal of applied pharmaceutics. 2018 Jul 7:1–5.

3. 3. Balakrishna T. Formulation and evaluation of lansoprazole fast dissolving buccal films. Asian Journal of Pharmaceutics (AJP). 2018 Aug 19;12(02).

4. 4. Pavankumar GV, Ramakrishna V, William GJ, Konde A. Formulation and evaluation of buccal films of salbutamol sulphate. Indian journal of pharmaceutical sciences. 2005;67(2):160-4.

5. 5. Poynard T, Lemaire M, Agostini H. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. European journal of gastroenterology & hepatology. 1995 Jul 1;7(7):661-5.